Tumor News and Research

RSS

New in vitro 12-cell line panel assay predicts anti-cancer drug activity

Southern Research Institute today announced a new service offering - a novel in vitro 12-cell line panel assay designed to predict drug activity and improve the success rate of drugs tested in xenograft models.

21 May 2014

Genprex initiates Phase II clinical trial of Oncoprex for late-stage lung cancer patients

Genprex, Inc. announced today that it has enrolled the first patient in a clinical trial evaluating its lead product candidate Oncoprex in combination with erlotinib (Tarceva) for late-stage lung cancer patients.

21 May 2014

Research provides key insights into most aggressive form of pancreatic cancer

Mayo Clinic researchers have discovered an enzyme they say is tightly linked to how aggressive pancreatic cancer will be in a patient.

21 May 2014

Substance from pine bark is a potential source for treating melanoma

A substance that comes from pine bark is a potential source for a new treatment of melanoma, according to Penn State College of Medicine researchers.

21 May 2014

FDA approves Takeda's Entyvio for severe active ulcerative colitis and Crohn's disease

Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., has announced that the United States (U.S.) Food and Drug Administration (FDA) simultaneously approved a new biologic therapy, Entyvio™ (vedolizumab), for the treatment of adults with moderately to severely active ulcerative colitis (UC) and Crohn's disease (CD).

21 May 2014

Space Station science: Microgravity on human thyroid carcinoma cells

The multi-national efforts that go into research aboard the International Space Station show that working together can yield results with universal benefits.

21 May 2014

Barnes-Jewish Hospital first to use VISIUS iMRI for over 1,000 procedures

IMRIS Inc. ("IMRIS" or the "Company") today announced that Barnes-Jewish Hospital in St. Louis is the first U.S. hospital to use VISIUS® iMRI for more than 1,000 procedures.

20 May 2014

SynCardia Total Artificial Heart achieves 1,300th milestone

SynCardia Systems, Inc. announced today that a United States patient with end-stage biventricular heart failure received the 1,300th implant of the SynCardia temporary Total Artificial Heart as a bridge to transplant in April 2014.

20 May 2014

TSRI chemists develop correct structure of highly promising anticancer compound

Chemists at The Scripps Research Institute (TSRI) have determined the correct structure of a highly promising anticancer compound approved by the U.S. Food and Drug Administration (FDA) for clinical trials in cancer patients.

20 May 2014

Low risk prostate cancer not always low risk

More and more men who believe they have low-risk prostate cancers are opting for active surveillance, forgoing treatment and monitoring the cancer closely with prostate-specific antigen (PSA) tests, digital rectal exams and ultrasounds at regular intervals to see if their tumors are growing. Nearly 400 men are now enrolled in the UCLA Active Surveillance program, the largest in Southern California.

19 May 2014

New ultra-sensitive nano-chip capable of detecting cancer at early stages

The majority of cancers are detected on the macroscopic level, when the tumor is already composed of millions of cancer cells and the disease is starting to advance into a more mature phase.

19 May 2014

Bio-Path Holdings reports net loss of $504,876 for first quarter 2014

Bio-Path Holdings, Inc., a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, today announced operational and financial results for the first quarter ended March 31, 2014.

17 May 2014

Specific Technologies unveils SpecID blood culture system at General Meeting of the American Society for Microbiology

Specific Technologies, developer of the SpecID™ system to rapidly detect and identify bacterial species and strain via a metabolomic fingerprint, today announced that for the first time it will showcase its transformative SpecID blood culture system at the 114th General Meeting of the American Society for Microbiology, May 17-20, 2014 in Boston, Massachusetts at the Boston Convention and Exhibition Center.

16 May 2014

Cook Medical to exhibit augmented reality experiences at AUA meeting

Cook Medical will exhibit augmented reality experiences, which is a technology used to simulate use of products, and host a skills challenge at their booth, #1617, at the annual American Urological Association meeting.

From COOK MEDICAL INC. 16 May 2014

Bristol-Myers Squibb announces study results of nivolumab drug in patients with renal cell carcinoma

Bristol-Myers Squibb Company today announced results from a Phase 2 and a Phase 1b study of its investigational PD-1 immune checkpoint inhibitor nivolumab in patients with advanced or metastatic renal cell carcinoma (RCC), commonly known as kidney cancer.

16 May 2014

Tumor News and Research

New in vitro 12-cell line panel assay predicts anti-cancer drug activity

Genprex initiates Phase II clinical trial of Oncoprex for late-stage lung cancer patients

Research provides key insights into most aggressive form of pancreatic cancer

Substance from pine bark is a potential source for treating melanoma

FDA approves Takeda's Entyvio for severe active ulcerative colitis and Crohn's disease

Space Station science: Microgravity on human thyroid carcinoma cells

Barnes-Jewish Hospital first to use VISIUS iMRI for over 1,000 procedures

SynCardia Total Artificial Heart achieves 1,300th milestone

TSRI chemists develop correct structure of highly promising anticancer compound

Low risk prostate cancer not always low risk

New ultra-sensitive nano-chip capable of detecting cancer at early stages

Bio-Path Holdings reports net loss of $504,876 for first quarter 2014

Specific Technologies unveils SpecID blood culture system at General Meeting of the American Society for Microbiology

Cook Medical to exhibit augmented reality experiences at AUA meeting

Bristol-Myers Squibb announces study results of nivolumab drug in patients with renal cell carcinoma

Bristol-Myers Squibb reports updated survival data from Phase 1b study of advanced melanoma

CHOP oncologist receives Lifetime Achievement Award at ANRA association's international meeting

Researchers test genomic sequencing for women with triple negative breast cancer

New tech could take light-based cancer treatment deep inside the body

EntreMed reports net loss of $1.5M in first quarter 2014

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest News